Erectile Dysfunction–our new study reveals trends, R&D progress, and predicted revenues Where is the erectile dysfunction market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead Our 168 pages report provides 88 tables, 85 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Erectile Dysfunction Market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, there are following segments, each forecasted at a global and regional level.
Erectile Dysfunction Market by Distribution Channel – Hospital Pharmacies – Retail Pharmacies – Online Pharmacies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 15 leading national markets:
• North America – U.S. – Canada
• Europe – Germany – France – UK – Italy – Spain – Rest of Europe
• Asia pacific – Japan – China – India – Australia – ASEAN – Rest of Asia Pacific
• Rest of the World – Brazil – Mexico – GCC – South Africa – Rest of ROW
The report also includes profiles and for some of the leading companies in the erectile dysfunction market.
Leading companies and the potential for market growth Overall world revenue for Erectile Dysfunction Market will surpass $2,500 million in 2020, our work calculates. We predict noticeable revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Erectile Dysfunction Market report helps you In summary, our 169 pages report provides you with the following knowledge:
Revenue forecasts to 2030 for 5 regional and 17 key national markets See forecasts for the Erectile Dysfunction market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa.
Prospects for established firms and those seeking to enter the market Including company profiles for 10 of the major companies involved in the erectile dysfunction market: • Bayer AG • Eli Lilly and Company • Ferring B.V. • GSK • Pfizer Inc. • Teva Pharmaceuticals • Vivus Inc. • Dong Pharmaceuticals • SK Chemicals Co Ltd. • Apricus Biosciences Inc.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Erectile Dysfunction market and leading companies. You will find data, trends and predictions.
Buy our report today Erectile Dysfunction Market Report 2020-2030: Forecasts by Type (Pharmaceuticals (Viagra (Sildenafil Citrate), Cialis (Tadalafil), Levitra/Staxyn (Vardenafil), Stendra/Spedra (Avanafil), Zydena (Udenafil), Vitaros (Alprostadil)) and Nutraceuticals (Dietary Supplements (DHEA, VIgRX Plus, IDIProst, Prelox, Tradamix TX 1000, Others); HerbalNatural, (Horny Goat Weed, Ginko, Red Ginseng, Yohimbine, Panax Ginseng, Cappra, Pyongenol, Lepidamax, REVACTIN, Others)), Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies). PLUS Profiles of Leading Companies) and Regional and Leading National Market Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Global Erectile Dysfunction Market 2020-2030 1.1 Market Overview 1.1 Why You Should Read This Report 1.2 What This Report Delivers 1.3 Key Questions Answered by This Analytical Report Include: 1.4 Who is This Report For? 1.5 Methodology 1.6 Frequently Asked Questions (FAQs) 1.7 Associated Visiongain Reports 1.8 About Visiongain
7 Global Erectile Dysfunction Market Size by Distribution Channel, Forecast 2020-2030 7.1.1 Hospital Pharmacies Forecast 2020-2030 7.1.2 Retail Pharmacies Forecast 2020-2030 7.1.3 Online Pharmacies Forecast 2020-2030
8 Regional and Leading National Erectile Dysfunction Market Forecasts 2020-2030 8.1 Global Erectile Dysfunction Market by National Market Share Forecast 2020-2030
9 North America Erectile Dysfunction Market 9.1 North America Erectile Dysfunction Market by Country Market Share Forecast 2020-2030 9.2 North America Erectile Dysfunction Market Forecast by Type, 2020-2030 9.3 North America Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 9.4 North America Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 9.5 North America Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 9.6 U.S. Erectile Dysfunction Market Forecast 2020-2030 9.7 Canada Erectile Dysfunction Market Forecast 2020-2030
10 Europe Erectile Dysfunction Market by Country Market Share Forecast 2020-2030 10.1 Europe Erectile Dysfunction Market Forecast by Type, 2020-2030 10.2 Europe Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 10.3 Europe Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 10.4 Europe Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 10.5 Germany Erectile Dysfunction Market Forecast 2020-2030 10.6 France Erectile Dysfunction Market Forecast 2020-2030 10.7 UK Erectile Dysfunction Market Forecast 2020-2030 10.8 Italy Erectile Dysfunction Market Forecast 2020-2030 10.9 Spain Erectile Dysfunction Market Forecast 2020-2030 10.10 Rest of Europe Erectile Dysfunction Market Forecast 2020-2030
11 Asia Pacific Erectile Dysfunction Market by Country, Forecast 2020-2030 11.1 Asia Pacific Erectile Dysfunction Market Forecast by Type, 2020-2030 11.2 Asia Pacific Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 11.3 Asia Pacific Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 11.4 Asia Pacific Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 11.5 Japan Erectile Dysfunction Market Forecast 2020-2030 11.6 China Erectile Dysfunction Market Forecast 2020-2030 11.7 India Erectile Dysfunction Market Forecast 2020-2030 11.8 Australia Erectile Dysfunction Market Forecast 2020-2030 11.9 ASEAN Erectile Dysfunction Market Forecast 2020-2030 11.10 Rest of Asia Pacific Erectile Dysfunction Market Forecast 2020-2030
12 Rest of the World (RoW) Erectile Dysfunction Market by Country Market Share Forecast 2020-2030 12.1 Rest of the World (RoW) Erectile Dysfunction Market Forecast by Type, 2020-2030 12.2 Rest of the World (RoW) Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 12.3 Rest of the World (RoW) Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 12.4 Rest of the World (RoW) Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 12.5 Brazil Erectile Dysfunction Market Forecast 2020-2030 12.6 Mexico Erectile Dysfunction Market Forecast 2020-2030 12.7 GCC Erectile Dysfunction Market Forecast 2020-2030 12.8 South Africa Erectile Dysfunction Market Forecast 2020-2030 12.9 Rest of RoW Erectile Dysfunction Market Forecast 2020-2030
13 Leading Companies in the Erectile Dysfunction Market 13.1 Bayer AG 13.1.1 Bayer AG Total Company Sales 2017-2019 13.1.2 Bayer AG Erectile Dysfunction Products / Services 13.1.3 Bayer AG. Mergers & Acquisitions (M&A) Activity 13.2 Eli Lilly and Company 13.2.1 Eli Lilly and Company Total Company Sales 2017-2019 13.2.2 Eli Lilly and Company Erectile Dysfunction Products / Services 13.2.3 Eli Lilly and Company. Mergers & Acquisitions (M&A) Activity 13.3 Ferring B.V. 13.3.1 Ferring B.V. Erectile Dysfunction Products / Services 13.3.2 Ferring B.V. Mergers & Acquisitions (M&A) Activity 13.4 GSK 13.4.1 GSK Total Company Sales 2017-2019 13.4.2 GSK Erectile Dysfunction Products / Services 13.4.3 GSK. Mergers & Acquisitions (M&A) Activity 13.5 Pfizer Inc. 13.5.1 Pfizer Inc. Total Company Sales 2017-2019 13.5.2 Pfizer Inc. Erectile Dysfunction Products / Services 13.5.3 Pfizer Inc. Mergers & Acquisitions (M&A) Activity 13.6 Teva Pharmaceuticals 13.6.1 Teva Pharmaceuticals Total Company Sales 2017-2019 13.6.1 Teva Pharmaceuticals Erectile Dysfunction Products / Services 13.6.2 Teva Pharmaceuticals. Mergers & Acquisitions (M&A) Activity 13.7 Vivus Inc. 13.7.1 Vivus Inc. Total Company Sales 2017-2019 13.7.2 Vivus Inc. Erectile Dysfunction Products / Services 13.7.3 Vivus Inc. Mergers & Acquisitions (M&A) Activity 13.8 Dong Pharmaceuticals 13.8.1 Dong Pharmaceuticals Erectile Dysfunction Products / Services 13.8.2 Dong Pharmaceuticals. Mergers & Acquisitions (M&A) Activity 13.9 SK Chemicals Co Ltd. 13.9.1 SK Chemicals Co Ltd. Total Company Sales 2017-2019 13.9.2 SK Chemicals Co Ltd. Erectile Dysfunction Products / Services 13.9.3 SK Chemicals Co Ltd. Mergers & Acquisitions (M&A) Activity 13.10 Apricus Biosciences Inc. 13.10.1 Apricus Biosciences Inc. Erectile Dysfunction Products / Services 13.10.2 Apricus Biosciences Inc. Mergers & Acquisitions (M&A) Activity
14 Conclusions and Recommendations 14.1 Associated Visiongain Reports Visiongain Report Sales Order Form
Appendix A About Visiongain Appendix B Visiongain report evaluation form
List of Tables Table 1. Global Erectile Dysfunction Market CAGR Forecast by Region 2020, 2025, 2030 (CAGR %) Table 2. Global Erectile Dysfunction Market Snapshot (2020-2030) Table 3. Global Erectile Dysfunction Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR %) Table 4. Pharmaceuticals Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 5. Nutraceuticals Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 6. Global Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (US$ million, AGR %, CAGR %) Table 7. Viagra (sildenafil citrate) Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 8. Cialis (tadalafil) Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 9. Levitra/ staxyn (Vardenafil) Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 10. Stendra/Spedra (avanafil) Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 11. Zydena (udenafil) Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 12. Vitaros (alprostadil) Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 13. Global Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (US$ million, AGR %, CAGR %) Table 14. Dietary Supplements Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 15. Global Dietary Supplements Market Forecast by Type, 2020-2030 (US$ million, CAGR %) Table 16. Herbal/Natural Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 17. Global Herbal/Natural Market Forecast by Type, 2020-2030 (US$ million, CAGR %) Table 18. Others Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 19. Global Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR %) Table 20. Hospital Pharmacies Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 21. Retail Pharmacies Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 22. Online Pharmacies Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%) Table 23. Global Erectile Dysfunction Market CAGR Forecast by Region 2020, 2025, 2030 (%) Table 24. North America Erectile Dysfunction Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR %) Table 25. North America Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (US$ million, AGR %, CAGR %) Table 26. North America Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (US$ million, AGR %, CAGR %) Table 27. North America Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR %) Table 28. U.S. Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 29. Canada Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 30. Europe Erectile Dysfunction Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR %) Table 31. Europe Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (US$ million, AGR %, CAGR %) Table 32. Europe Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (US$ million, AGR %, CAGR %) Table 33. Europe Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR %) Table 34. Germany Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 35. France Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 36. UK Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 37. Italy Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 38. Spain Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 39. Rest of Europe Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 40. Asia Pacific Erectile Dysfunction Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR %) Table 41. Asia Pacific Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (US$ million, AGR %, CAGR %) Table 42. Asia Pacific Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (US$ million, AGR %, CAGR %) Table 43. Asia Pacific Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR %) Table 44. Japan Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 45. China Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 46. India Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 47. Australia Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 48. ASEAN Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 49. Rest of Asia Pacific Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 50. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR %) Table 51. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (US$ million, AGR %, CAGR %) Table 52. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (US$ million, AGR %, CAGR %) Table 53. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR %) Table 54. Brazil Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 55. Mexico Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 56. GCC Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 57. South Africa Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 58. Rest of RoW Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %) Table 59. Bayer AG Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded) Table 60. Bayer AG Total Company Sales 2017-2019 (US million, AGR %) Table 61. Bayer AG Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details) Table 62. Eli Lilly and Company Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded) Table 63. Eli Lilly and Company Total Company Sales 2017-2019 (US$ million, AGR %) Table 64. Eli Lilly and Company Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details) Table 65. Ferring B.V. Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded) Table 66. Ferring B.V. Total Company Sales 2017-2019 (US$ million, AGR %) Table 67. Ferring B.V. Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details) Table 68. GSK Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded) Table 69. GSK Total Company Sales 2017-2019 (US$ million, AGR %) Table 70. GSK Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details) Table 71. Pfizer Inc. Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded) Table 72. Pfizer Inc. Total Company Sales 2017-2019 (US$ billion, AGR %) Table 73. Pfizer Inc. Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details) Table 74. Teva Pharmaceuticals Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded) Table 75. Teva Pharmaceuticals Total Company Sales 2017-2019 (US$ billion, AGR %) Table 76. Teva Pharmaceuticals Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details) Table 77. Vivus Inc. Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded) Table 78. Vivus Inc. Total Company Sales 2017-2019 (US$ million, AGR %) Table 79. Vivus Inc. Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details) Table 80. Dong Pharmaceuticals Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded) Table 81. Dong Pharmaceuticals Total Company Sales 2017-2019 (US$ million, AGR %) Table 82. Dong Pharmaceuticals Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details) Table 83. SK Chemicals Co Ltd. Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded) Table 84. SK Chemicals Co Ltd. Total Company Sales 2017-2019 (US$ million, AGR %) Table 85. SK Chemicals Co Ltd. Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details) Table 86. Apricus Biosciences Inc. Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded) Table 87. Apricus Biosciences Inc. Total Company Sales 2017-2019 (US$ million, AGR %) Table 88. Apricus Biosciences Inc. Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details)
List of Figures Figure 1. Research Methodology Snapshot, Erectile Dysfunction Market, 2020 Figure 2. Global Erectile Dysfunction Market Segmentation Figure 3. Global Erectile Dysfunction Market Drivers & Restraints, 2020-2030 Figure 4. SWOT Analysis – Erectile Dysfunction Market, 2020 Figure 5. Porter’s Analysis – Erectile Dysfunction Market, 2020 Figure 6. PEST Analysis – Erectile Dysfunction Market, 2020 Figure 7. Global Erectile Dysfunction Market Forecast by Type, 2020-2030 (US$ million, AGR %) Figure 8. Global Erectile Dysfunction Market Share Forecast by Type, 2020, 2025, 2030 (%) Figure 9. Pharmaceuticals Revenue Forecast 2020-2030 (US$ million, AGR %) Figure 10. Nutraceuticals Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 11. Global Erectile Dysfunction Market by Pharmaceuticals,2020-2030 Figure 12. Global Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (US$ million, AGR %) Figure 13. Global Erectile Dysfunction Market Share Forecast by Pharmaceuticals, 2020, 2025, 2030 (%) Figure 14. Viagra (sildenafil citrate) Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 15. Cialis (tadalafil) Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 16. Levitra/ staxyn (Vardenafil) Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 17. Stendra/Spedra (avanafil) Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 18. Zydena (udenafil) Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 19. Vitaros (alprostadil) Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 20. Global Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (US$ million, AGR %) Figure 21. Global Erectile Dysfunction Market Share Forecast by Nutraceuticals, 2020, 2025, 2030 (%) Figure 22. Dietary Supplements Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 23. Global Dietary Supplements Market Forecast by Type, 2020-2030 (US$ million, AGR %) Figure 24. Herbal/Natural Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 25. Global Herbal/Natural Market Forecast by Type, 2020-2030 (US$ million, AGR %) Figure 26. Others Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 27. Global Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %) Figure 28. Global Erectile Dysfunction Market Share Forecast by Distribution Channel, 2020, 2025, 2030 (%) Figure 29. Hospital Pharmacies Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 30. Retail Pharmacies Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 31. Online Pharmacies Revenue Forecast 2020-2030 (US$ million, AGR%) Figure 32. Global Erectile Dysfunction Market Forecast by Region 2020-2030 (US$ million, AGR %) Figure 33. Global Erectile Dysfunction Market Share Forecast by Region 2020, 2025, 2030 (%) Figure 34. North America Erectile Dysfunction Market Forecast by Country 2020-2030 (US$ million, AGR %) Figure 35. North America Erectile Dysfunction Market Share Forecast by Country 2020, 2025, 2030 (%) Figure 36. North America Erectile Dysfunction Market Forecast by Type, 2020-2030 Revenue (US$ million), (AGR %) Figure 37. North America Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 Revenue (US$ million), (AGR %) Figure 38. North America Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 Revenue (US$ million), (AGR %) Figure 39. North America Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 Revenue (US$ million), (AGR %) Figure 40. U.S. Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 41. Canada Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 42. Europe Erectile Dysfunction Market Forecast by Country 2020-2030 (US$ million, AGR %) Figure 43. Europe Erectile Dysfunction Market Share Forecast by Country 2020, 2025, 2030 (%) Figure 44. Europe Erectile Dysfunction Market Forecast by Type, 2020-2030 Revenue (US$ million), (AGR %) Figure 45. Europe Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 Revenue (US$ million), (AGR %) Figure 46. Europe Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 Revenue (US$ million), (AGR %) Figure 47. Europe Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 Revenue (US$ million), AGR (%) Figure 48. Germany Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 49. France Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 50. UK Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 51. Italy Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 52. Spain Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 53. Rest of Europe Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 54. Asia Pacific Erectile Dysfunction Market Forecast by Country 2020-2030 (US$ million, AGR %) Figure 55. Asia Pacific Erectile Dysfunction Market Share Forecast by Country 2020, 2025, 2030 (%) Figure 56. Asia Pacific Erectile Dysfunction Market Forecast by Type, 2020-2030 Revenue (US$ million), (AGR %) Figure 57. Asia Pacific Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 Revenue (US$ million) (AGR %) Figure 58. Asia Pacific Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 Revenue (US$ million), (AGR %) Figure 59. Asia Pacific Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (AGR %) Figure 60. Japan Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 61. China Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 62. India Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 63. Australia Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 64. ASEAN Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 65. Rest of Asia Pacific Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 66. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Country 2020-2030 (US$ million, AGR %) Figure 67. Rest of the World (RoW) Erectile Dysfunction Market Share Forecast by Country 2020, 2025, 2030 (%) Figure 68. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Type, 2020-2030 Revenue (US$ million), (AGR %) Figure 69. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (AGR %) Figure 70. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (AGR %) Figure 71. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (AGR %) Figure 72. Brazil Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 73. Mexico Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 74. GCC Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 75. South Africa Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 76. Rest of RoW Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %) Figure 77. Bayer AG Total Company Sales 2017-2019 (US$ million, AGR %) Figure 78. Eli Lilly and Company Total Company Sales 2017-2019 (US$ million, AGR %) Figure 79. GSK Total Company Sales 2017-2019 (US$ million, AGR %) Figure 80. Pfizer Inc. Total Company Sales 2017-2019 (US$ bn, AGR %) Figure 81. Teva Pharmaceuticals Total Company Sales 2017-2019 (US$ billion, AGR %) Figure 82. Vivus Inc. Total Company Sales 2017-2019 (US$ million, AGR %) Figure 83. SK Chemicals Co Ltd. Total Company Sales 2017-2019 (US$ million, AGR %) Figure 84. Global Erectile Dysfunction Market Forecast by Region 2020-2030 (US$ million, AGR %) Figure 85. Global Erectile Dysfunction Market Share Forecast by Region 2020, 2025, 2030 (%)
Apricus Biosciences Inc. Bayer AG Dong Pharmaceuticals Eli Lilly and Company Ferring B.V. GSK Pfizer Inc. SK Chemicals Co Ltd. Teva Pharmaceuticals Vivus Inc.
Download sample pages
Complete the form below to download your free sample pages for Erectile Dysfunction Nutraceuticals Market Report 2020-2030
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
